1. Home
  2. VYNE vs ATER Comparison

VYNE vs ATER Comparison

Compare VYNE & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • ATER
  • Stock Information
  • Founded
  • VYNE 2003
  • ATER 2014
  • Country
  • VYNE United States
  • ATER United States
  • Employees
  • VYNE N/A
  • ATER N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • VYNE Health Care
  • ATER Consumer Discretionary
  • Exchange
  • VYNE Nasdaq
  • ATER Nasdaq
  • Market Cap
  • VYNE 16.0M
  • ATER 15.5M
  • IPO Year
  • VYNE 2018
  • ATER N/A
  • Fundamental
  • Price
  • VYNE $1.45
  • ATER $1.53
  • Analyst Decision
  • VYNE Strong Buy
  • ATER
  • Analyst Count
  • VYNE 2
  • ATER 0
  • Target Price
  • VYNE $6.25
  • ATER N/A
  • AVG Volume (30 Days)
  • VYNE 1.3M
  • ATER 245.4K
  • Earning Date
  • VYNE 08-13-2025
  • ATER 08-07-2025
  • Dividend Yield
  • VYNE N/A
  • ATER N/A
  • EPS Growth
  • VYNE N/A
  • ATER N/A
  • EPS
  • VYNE N/A
  • ATER N/A
  • Revenue
  • VYNE $605,000.00
  • ATER $94,191,000.00
  • Revenue This Year
  • VYNE $42.51
  • ATER N/A
  • Revenue Next Year
  • VYNE N/A
  • ATER $7.48
  • P/E Ratio
  • VYNE N/A
  • ATER N/A
  • Revenue Growth
  • VYNE 43.03
  • ATER N/A
  • 52 Week Low
  • VYNE $0.85
  • ATER $1.22
  • 52 Week High
  • VYNE $4.30
  • ATER $3.84
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 56.76
  • ATER 49.53
  • Support Level
  • VYNE $0.85
  • ATER $1.56
  • Resistance Level
  • VYNE $1.96
  • ATER $1.80
  • Average True Range (ATR)
  • VYNE 0.20
  • ATER 0.15
  • MACD
  • VYNE 0.07
  • ATER 0.03
  • Stochastic Oscillator
  • VYNE 51.80
  • ATER 56.90

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: